Mineralys Therapeutics CEO Sells Shares
I'm PortAI, I can summarize articles.
Jon Congleton, CEO of Mineralys Therapeutics, sold 16,236 shares of common stock on January 12, 2026, under a Rule 10b5-1 trading plan. The sales included 9,119 shares at an average price of $32.2083 and 7,117 shares at $33.1505, totaling $529,639. After the sales, Congleton retains ownership of 639,151 shares in the company.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments